Exclusive Sell-Side Advisor
SDSRx
About the Company
SDS Rx (“SDS”), a provider of healthcare delivery services, specializes in the movement of pharmaceuticals from wholesale distributors to pharmacies, as well as from long-term care (“LTC”) pharmacies to LTC facilities. SDS leverages an asset-light model and executes its deliveries through a network of independent contractors. The Company enjoyed strong historical growth through its value-added operational model and its focus on pharmaceutical products.
has been recapitalized by
Exclusive Sell-Side Advisor
Situation
The SDS management team was seeking a value-add partner to help recapitalize the business and execute its clear growth strategy.
Engagement
G2 was engaged to analyze and advise on potential strategic alternatives, as well as to identify and pursue potential growth opportunities – including sourcing capital from the traditional debt lending and private equity markets. Management ultimately selected a majority recapitalization and called on G2 to run a high-touch process to successfully execute the transaction.
Outcome
The transaction was successfully executed in May 2018 through a recapitalization with HCI Equity Partners.
Deal Team
Sub-Sector
- Final Mile Delivery
Contact
Let’s talk about how we can help your business.
Whether you are experiencing strong growth or periods of distress, our team is exceptionally prepared to support your strategic objectives with bespoke solutions. There is no one size fits all approach.